Cargando…

Progress in clinical genetics of prostate cancer

Detalles Bibliográficos
Autores principales:	Cybulski, C, Wokołorczyk, D
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3108171/ http://dx.doi.org/10.1186/1897-4287-9-S2-A6

Ejemplares similares

NBS1 Mutation and prognosis of prostate cancer
por: Wokołorczyk, Dominika, et al.
Publicado: (2012)

HOXB13 mutations and prostate cancer in Poland
por: Kluźniak, Wojciech, et al.
Publicado: (2012)

Prostate cancer screening based on genotyping for high risk founder alleles
por: Cybulski, Cezary, et al.
Publicado: (2012)

DNA testing for high risk of prostate cancer
por: Wokołorczyk, Dominika
Publicado: (2012)

The risk of breast cancer in women with a CHEK2 mutation
por: Cybulski, Cezary, et al.
Publicado: (2012)

CHEK2 mutations as markers for high risk of breast cancer
por: Cybulski, Cezary, et al.
Publicado: (2012)

Clinical genetics in cancer prevention
por: Elsakov , Pavel
Publicado: (2012)

Molecular analyses of human breast cancer metastasis: genetic markers of progression
por: Driouch, K, et al.
Publicado: (2000)

Prostatic mapping in diagnosis and follow-up for prostatic cancer patients treated by CT-RT
por: Azzarello, Guido, et al.
Publicado: (2009)

Why choose the treatment with cisplatin for BRCA1 breast cancers patients?
por: Byrski, T, et al.
Publicado: (2012)

Neoadjuvant therapy with cisplatin in BRCA1-positive breast cancer patients
por: Byrski, T, et al.
Publicado: (2011)

Clinical genetics of melanoma
por: Debniak, T
Publicado: (2011)

Genome-proteome system for prostate cancer
por: Peshkov, Maxim N
Publicado: (2014)

Clinical genetics of melanoma
por: Dębniak, T
Publicado: (2012)

Clinical practice improvement in the genetics clinic
por: Greening, S
Publicado: (2012)

Meeting abstracts from the Annual Conference “Clinical Genetics of Cancer 2022”
Publicado: (2023)

The CHEK 2 GENE mutations and the risk of Gastric cancer
por: Teodorczyk, Urszula, et al.
Publicado: (2012)

RAD21 overexpression is frequently observed in BRCA-X Prostate Cancers
por: Deb, S, et al.
Publicado: (2012)

Iron and breast cancer risk
por: Sukiennicki, Grzegorz, et al.
Publicado: (2012)

Clinical Genetics of Cancer 2017: Szczecin, Poland. 21-22 September 2017
Publicado: (2018)

Meeting abstracts from the Annual Conference on Hereditary Cancers 2016: Szczecin, Poland. 14-15 September 2016
por: Cybulski, C., et al.
Publicado: (2017)

Mutations and polymorphisms of genes moderate increase in gastric cancer risk
por: Teodorczyk, Urszula, et al.
Publicado: (2012)

Selenium (Se) and the risk of breast, ovarian and prostate cancers
por: Jaworska, Katarzyna, et al.
Publicado: (2012)

Interaction of prostate cancer and neurons – the neuro-neoplastic synapse
por: Voss, MJ, et al.
Publicado: (2009)

Serum concentration of iron as predictor of cancer risk among BRCA1 mutation carriers
por: Sukiennicki, Grzegorz, et al.
Publicado: (2012)

Folic acid and cancer risk in BRCA1 carriers
por: Durda, Katarzyna, et al.
Publicado: (2012)

Serum concentration of selected macro- and microelements and their correlation with the risk of breast and ovarian cancer among BRCA1 mutation carriers
por: Muszyńska, Magdalena, et al.
Publicado: (2012)

Neoadjuvant chemotherapy with Cisplatin in BRCA1 mutation carriers – results of treatment
por: Byrski, T, et al.
Publicado: (2012)

Pathological complete response to neoadjuvant cisplatin in BRCA1-positive breast cancer patients
por: Byrski, Tomasz, et al.
Publicado: (2015)

Prospective observation of breast/ovarian cancer risk in BRCA1 carriers depending on serum selenium level optimized with diet
por: Lubiński, J, et al.
Publicado: (2012)

Serum levels of markers in early detection of prostate cancer (pilote study)
por: Fuchsova, Radka, et al.
Publicado: (2014)

Copper as diagnostic marker of cancers
por: Muszyńska, Magdalena, et al.
Publicado: (2015)

PW02-031 - Genetic and clinical manifestations of CAPS
por: Bybee, AK, et al.
Publicado: (2013)

Magnesium as a diagnostic marker of cancer
por: Marciniak, Wojciech, et al.
Publicado: (2015)

Genetic insights into breast cancer risk
por: Wong-Brown, Michelle, et al.
Publicado: (2015)

Screening with Magnetic Resonance Imaging in women at low and intermediate risk of breast Cancer
por: Huzarski, T T, et al.
Publicado: (2012)

Selenium as diagnostic marker of cancers
por: Jaworska-Bieniek, Katarzyna, et al.
Publicado: (2015)

Zinc as diagnostic marker of cancers
por: Kaczmarek, Katarzyna, et al.
Publicado: (2015)

Iron as diagnostic marker of cancer
por: Sukiennicki, Grzegorz, et al.
Publicado: (2015)

Neurodegenerative diseases: complexity of clinical phenotypes in genetic models of alzheimer’s disease and frontotemporal dementia
por: Bruni, A C
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_1aq9bdpl0tj2an1re4tkhl5jum